Papillary craniopharyngioma in a 4-year-old girl with BRAF V600E mutation: a case report and review of the literature
Open Access
- 1 August 2018
- journal article
- review article
- Published by Springer Science and Business Media LLC in Child's Nervous System
- Vol. 35 (1), 169-173
- https://doi.org/10.1007/s00381-018-3925-4
Abstract
Introduction Craniopharyngiomas are one of the most frequently diagnosed hypothalamo-pituitary tumors in childhood. The adamantinomatous histological subtype accounts for most pediatric cases, while the papillary variant is almost exclusively diagnosed in adults. Here, we report a case of papillary craniopharyngioma in a very young child, confirmed by molecular tissue analysis. Case report A 4-year-old girl was being investigated for symptomatic central hypothyroidism. Brain MR imaging revealed a large solid/cystic suprasellar mass, splaying the optic chiasm and measuring 3 × 1.9 × 2.3 cm. The patient underwent a transsphenoidal near total resection of the lesion, which was encased within a tumor capsule. Post-operatively, the patient developed transient diabetes insipidus but otherwise recovered well. The pathology of the lesion was consistent with a papillary craniopharyngioma with regions of stratified squamous epithelium accompanied by superficial goblet cells and ciliated cells. Subsequent next-generation sequencing analysis of the lesion confirmed the presence of a BRAF V600E mutation (BRAFc.1799T>A p. (Val600Glu). To date, she remains free from progression 1 year following surgery. Conclusion This is the youngest case published to date of papillary craniopharyngioma with a confirmed BRAF V600E mutation. The case encourages discussion about the most appropriate adjuvant therapy for tumor progression in such cases, given the risks of radiotherapy to the developing brain and the increasing availability of oral BRAF inhibitor therapy.Funding Information
- University of Manchester
This publication has 29 references indexed in Scilit:
- Targeted therapy for infants with diencephalic syndrome: A case report and review of management strategiesPediatric Blood & Cancer, 2018
- Papillary craniopharyngioma: A clinicopathologic study of a rare entity from a major tertiary care center in PakistanNeurology India, 2017
- Successful Retreatment of a Child with a Refractory Brainstem Ganglioglioma with VemurafenibPediatric Blood & Cancer, 2015
- BRAF V600E analysis for the differentiation of papillary craniopharyngiomas and Rathke's cleft cystsNeuropathology and Applied Neurobiology, 2014
- Markers of Recurrence and Long-Term Morbidity in Craniopharyngioma: A Systematic Analysis of 171 PatientsJournal of Clinical Endocrinology & Metabolism, 2012
- Clinicopathological Characteristics of Adamantinomatous and Papillary Craniopharyngiomas: University of California, San Francisco Experience 1985-2005Neurosurgery, 2010
- Does chemotherapy have a role in the management of craniopharyngioma?2006
- Phase II trial of conformal radiation therapy for pediatric patients with craniopharyngioma and correlation of surgical factors and radiation dosimetry with change in cognitive functionJournal of Neurosurgery: Pediatrics, 2006
- Clinical outcome in children with craniopharyngioma treated with primary surgery and radiotherapy deferred until relapseMedical and Pediatric Oncology, 2003
- Papillary craniopharyngioma: a clinicopathological study of 48 casesJournal of Neurosurgery, 1995